FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

350691000119103: agranulocytose door en volgend op toedienen van antineoplastisch middel (aandoening)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4555664011 Agranulocytosis due to and following administration of antineoplastic agent (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4555665012 Agranulocytosis due to and following cancer chemotherapy en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4555666013 Agranulocytosis due to and following administration of antineoplastic agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
12947781000146112 agranulocytose door en volgend op toedienen van antineoplastisch middel nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
12947791000146114 agranulocytose door en volgend op toedienen van antineoplastisch middel (aandoening) nl Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
12947861000146112 agranulocytose door en volgend op toedienen van chemotherapeutische stof tegen kanker nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agranulocytosis due to and following administration of antineoplastic agent (disorder) Due to Administration of antineoplastic agent true Inferred relationship Some 3
Agranulocytosis due to and following administration of antineoplastic agent (disorder) After Administration of antineoplastic agent true Inferred relationship Some 1
Agranulocytosis due to and following administration of antineoplastic agent (disorder) Pathological process (attribute) Abnormal immune process (qualifier value) true Inferred relationship Some 2
Agranulocytosis due to and following administration of antineoplastic agent (disorder) Is a Complication of introduction procedure true Inferred relationship Some
Agranulocytosis due to and following administration of antineoplastic agent (disorder) Is a Complication of chemotherapy (disorder) true Inferred relationship Some
Agranulocytosis due to and following administration of antineoplastic agent (disorder) Is a Agranulocytosis true Inferred relationship Some
Agranulocytosis due to and following administration of antineoplastic agent (disorder) Is a Disorder following clinical procedure true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

GB English

US English

Back to Start